Concorde Asset Management’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | $284K | Hold |
|
|||||
|
2024
Q4 | $375K | Hold |
|
|||||
|
2024
Q3 | $519K | Sell |
|
|||||
|
2024
Q2 | $702K | Buy |
|
|||||
|
2024
Q1 | $585K | Sell |
|
|||||
|
2023
Q4 | $492K | Buy |
|
|||||
|
2023
Q3 | $409K | Sell |
|
|||||
|
2023
Q2 | $371K | Buy |
|
|||||
|
2023
Q1 | $358K | Hold |
|
|||||
|
2022
Q4 | $305K | Sell |
|
|||||
|
2022
Q3 | $306K | Buy |
|
|||||
|
2022
Q2 | $337K | Hold |
|
|||||
|
2022
Q1 | $336K | Sell |
|
|||||
|
2021
Q4 | $340K | Hold |
|
|||||
|
2021
Q3 | $292K | Buy |
|
|||||
|
2021
Q2 | $252K | Hold |
|
|||||
|
2021
Q1 | $203K | Hold |
|
|||||
|
2020
Q4 | $211K | Buy |
|
|||||
|
2020
Q3 | $208K | Buy |
|